Elzer R, Houdek D L
Governors State University, USA.
Clin Nurse Spec. 1998 Nov;12(6):238-43; quiz 244-5. doi: 10.1097/00002800-199811000-00010.
Heparin-induced thrombocytopenia (HIT) and its two subtypes, early onset (Type I) and delayed onset (Type II), are becoming an increasing concern in acute care. Also called "white clot syndrome," this condition can lead to thrombosis and loss of limb. Alternatives to heparin therapy, such as low molecular weight heparin, are discussed as ways to decrease HIT. An algorithm has been developed to guide identification and monitoring of patients at risk for HIT. The article presents the expanded role of the clinical nurse specialist as case manager in clinically managing patients with actual or potential HIT. The case manager's role for patients receiving heparin lies in increasing the awareness of this condition among all clinicians and serving as a resource for current information regarding its prevention, diagnosis, and treatment.
肝素诱导的血小板减少症(HIT)及其两种亚型,即早发型(I型)和迟发型(II型),在急性护理中日益受到关注。这种情况也被称为“白色血栓综合征”,可导致血栓形成和肢体丧失。文中讨论了肝素治疗的替代方法,如低分子量肝素,作为降低HIT风险的途径。已开发出一种算法来指导对HIT高危患者的识别和监测。本文介绍了临床护理专家作为病例管理者在临床管理实际或潜在HIT患者方面的扩展作用。病例管理者在为接受肝素治疗的患者提供服务时,其作用在于提高所有临床医生对这种疾病的认识,并作为有关其预防、诊断和治疗的最新信息的资源提供者。